March 11, 2026 — Royal Philips has announced the expansion of its digital pathology portfolio with new cloud-enabled capabilities designed to help healthcare organizations scale digital diagnostics, improve productivity, and advance their transformation to fully digital workflows.

March 25,  2026 A Penn Medicine–led team has developed a first‑of‑its‑kind artificial intelligence system that interprets cardiac MRI scans with performance approaching expert clinicians. Trained on more than 300,000 MRI video clips from roughly 20,000 patients, the model can assess heart function and diagnose dozens of diseases using only non‑contrast imaging. The work was published in Nature Biomedical Engineering.

March 24, 2026 — MARS Bioimaging, a New Zealand–headquartered medical device company, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its portable photon-counting CT scanner for upper extremity imaging.

Designed for use in community and point-of-care settings, the MARS Bioimaging Extremity Scanner System delivers premium, high-resolution 3D X-ray images that visualize soft tissue, bone, blood vessels and metallic implants with clear material differentiation.

March 23, 2026 —Sacumen has launched ConnectX, a unified AI platform that gives cybersecurity product companies full command of their connector ecosystems — from initial deployment and validation to continuous testing, real-time monitoring, and around-the-clock support. The platform made its global debut at RSA Conference (RSAC) 2026 in San Francisco.

March 20, 2026 — Siemens Healthineers recently announced its Varian TrueBeam radiotherapy systems, which include TrueBeam, TrueBeam STx, VitalBeam and Edge, have received FDA 510(k) clearance for the use of low-dose radiation therapy (LDRT) in adults with medically refractory osteoarthritis (OA). This clearance expands Varian’s radiotherapy systems beyond cancer care into chronic musculoskeletal conditions, bringing precision radiotherapy to millions of people living with persistent pain and limited mobility.

March 23, 2026 — Leica Biosystems, a Danaher Company, has announced the US launch of the Aperio GT Elite scanner, along with Aperio iQC software incorporating unique rescan functionality. Together, these innovations deliver unmatched speed, intelligence, and workflow certainty to help accelerate slide processing and review while advancing cancer research for improved outcomes.

March 18, 2026 — FluoGuide A/S, a biotech company maximizing surgical outcomes in oncology, has announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to FG001 as an intraoperative imaging agent to guide surgical resection of high-grade glioma.

U.S. FDA Fast Track is a process designed to facilitate the development and expedite the review of drugs to treat serious conditions and fill an unmet medical need. The purpose is to get important new drugs to patients earlier.

March 23, 2026 — GE HealthCare has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for Photonova Spectra,1 a photon‑counting computed tomography (PCCT) solution powered by the company’s Deep Silicon detector technology and offered as a flexible platform with multiple configurations to meet diverse clinical needs.

March 17, 2026 – OXOS Medical recently announced that its MC2 portable X-ray system is now cleared for pediatric imaging, enabling providers to deliver quality, low-dose X-ray imaging to young patients. 

Traditional imaging rooms can be intimidating for childrenand stressful for parents2.  MC2 changes the dynamic by making the exam and imaging room one and the same, meeting young patients where they are comfortable, close to their loved ones. 

March 23, 2026 — Samsung Medison hsa announced that its U.S. medical imaging businesses, previously operating as Neurologica and Boston Imaging, will unify under a new corporate identity, Samsung HME (Healthcare and Medical Equipment) America. This transition brings the company’s U.S. ultrasound, digital radiography and computed tomography (CT) operations under one integrated structure that reflects the global Samsung brand behind its technology. 

Subscribe Now